What is Polarean Imaging Operating Cash Flow per Share?
Polarean Imaging's operating cash flow per share for the
six
months ended in Jun. 2023 was £-0.03.
Polarean Imaging's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.05.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -12.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 6.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Polarean Imaging's Operating Cash Flow per Share or its related term are showing as below:
LSE:POLX'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -12.5 Med: 14.5 Max: 61.3
Current: -12.5
During the past 7 years, Polarean Imaging's highest 3-Year average Operating Cash Flow per Share Growth Rate was 61.30% per year. The lowest was -12.50% per year. And the median was 14.50% per year.
LSE:POLX's 3-Year OCF Growth Rate is ranked worse than 69.2% of 685
companies
in the Medical Devices & Instruments industry
Industry Median: 2.6
vs LSE:POLX: -12.50
Polarean Imaging Operating Cash Flow per Share Historical Data
The historical data trend for Polarean Imaging's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Polarean Imaging Operating Cash Flow per Share Chart
Competitive Comparison of Polarean Imaging's Operating Cash Flow per Share
For the Medical Devices subindustry, Polarean Imaging's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polarean Imaging's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Polarean Imaging's Price-to-Operating-Cash-Flow falls into.
Polarean Imaging Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Polarean Imaging's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.05
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polarean Imaging Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Polarean Imaging's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:POLX has been successfully added to your 